Mustafa Solak, M.D. is a medical doctor who graduated from Hacettepe University School of Medicine and has completed residencies at Istanbul Sisli Etfal Teaching and Research Hospital and a fellowship at Hacettepe University Cancer Institute. He specializes in Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, and Gastrointestinal Cancers. He has also worked at the University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.
Read moreProf. Hale Başak Çağlar is a radiation oncology director and expert in treating breast, lung, pancreatic, prostate and bone cancer. She is highly qualified, having obtained her education from Gazi University, Marmara University and Medipol University, and is a member of numerous societies, such as the American Society for Therapeutic Radiation Oncology, the European Society for Therapeutic Radiation Oncology, the European Organisation for Research and Treatment of Cancer and the Radiosurgery Society.
Read moreDr. Ofer Merimsly is the best sarcoma, lymphoma, and lung cancer doctor within Israel and in the world. Also specializes in Whipple surgery treatment for patients with pancreatic cancer. Head of the National Center for sarcomas of bone and soft tissues of the Tel Aviv Medical Center Sourasky (Ichilov).
Specialty:
Education and specialization:
Membership:
2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career
Medicine Department of Internal Medicine
2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital
2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology
2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital
2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology
Memberships in Scientific Organizations
ASCO
ESMO
TTOD
AVOD
Publications
In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.
Awards Received
EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award
"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"
Speeches Delivered at National Congresses, Conferences, and Symposia:
Courses, Meetings, and Certificates
ESMO certified Medical Oncologist since 2019
Read moreDr. Verges graduated in Medicine and Surgery from the University of Barcelona in 1980 and moved to Boston (USA) to conduct basic research in ophthalmology, obtaining a PhD in Biology from Harvard University and defending his doctoral thesis on the mechanisms of tear secretion, which would become the basis for understanding the pathology of dry eye syndrome (thesis presented in Barcelona, 1983) and which earned him the National Research Prize (1983).
Currently, Dr. Carlos Verges carries out his professional activity as the Director of the Ophthalmology Service of the Dexéus University Hospital, together with his entire medical team from the advanced ophthalmology department, where he has a high-quality technological, medical and surgical team.
His area of interest is focused on the field of cataract and neurophysiological mechanisms of vision, especially in relation to sports.
Professional experience
1983-1986 Associate Professor, Department of Ophthalmology, Faculty of Medicine, University of Barcelona, Spain
1986-1989 Head of the Anterior Segment Unit, Department of Ophthalmology, Barcelona Hospital Clinic, Spain.
1986-1991 Professor of Ophthalmology, Faculty of Medicine, University of Barcelona, Spain.
1990-1992 Head of Ophthalmology Service, Hospital del Mar, Barcelona.
1989-1999 Head of the Ophthalmology Department, Sagrada Familia Clinic, Barcelona, Spain.
From 2000 to present, President and CEO of the Dr. Carlos Verges Private Foundation.
2000-2007 Head of the Ophthalmology Department, Institut Universitari Dexeus, Barcelona, Spain.
2007 – present General Director of the “Advanced Ophthalmology Department Dr. Verges”, Barcelona, Spain.
2018-present President and Head of the Department of Ophthalmology. University Hospital Dexeus Quironsalud. Polytechnic University of Catalonia.
Awards :
- National Research Prize 1984. Ministry of Education and Science: "The mechanism of tear secretion. The importance of beta-adrenergic receptors in the lacrimation of the lacrimal glands."
- National Prize for the best doctoral dissertation, Shibre Medal, 1984 "Personal contribution to the study of labial secretion. Determination of beta-adrenergic receptors in tear cells"
- National Pharmaceutical Industry Award 1987: "Treatment of immunological rejection in corneal transplantation using cyclosporine A."
- American Society of Implant Refractive Surgery (ASCRS) Award for the best scientific video presented at the annual conference: "Pseudo-Real Housing". First Prize. Seattle, USA, April 1999.
- Award for the most important technical innovation of 1999 from the Spanish Society.
Implantation-refractive surgery. Speaking at the National Congress held in Madrid 1999.
- 2000 Best Scientific Contribution Award "Laser Non-Penetrating Deep Sclerectomy" presented at the American Academy of Ophthalmology Meeting, AAO - Dallas, USA, October 2000.
- Best Paper Award for “GDx Analysis of Retinal Nerve Fiber Layer Thickness after LASIK” presented at the American Society of Cataract and Refractive Surgery, ASCRS, May 2004, San Diego, USA.
- Finalist for the King Jaume I Prize for Basic Research, 2005, sponsored by the Board of Trustees of the Generalitat of Valencia and the Valencian Foundation for Advanced Research.
- Surgical Technical Video Award: "MICS under Vision ICL, The Hook Technique"
Presented at the IX International Congress of Cataract and Refractive Surgery, May/June 2006, Belo Horizonte, Brazil.
Membership in scientific societies
Member of the Executive Board of the International Society of Refractive Surgery (ISRS) and the American Academy of Ophthalmology (AAO).
Member of the editorial board of Ophthalmology Times. Europe.
Member of the editorial board of Cataract and Refractive Surgery (USA).
Member of the Editorial Board of Cataract and Refractive Surgery Today Europe.
Member of the European Society of Cataract and Refractive Surgery (ESCRS).
Scientific reviewer of the journal: Cornea, Journal of Cataract and Refractive Surgery, American Academy of Ophthalmology, Cataract and Refractive Surgery and Archives of the Spanish Society of Ophthalmology.
Read more20 top ranked CyberKnife for lung cancer doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.
The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.
Top 5 CyberKnife for lung cancer doctors on Bookimed.com:
The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.
Famous CyberKnife for lung cancer doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.
The price for the consultation on CyberKnife for lung cancer varies between experts and depends on certain factors, such as:
To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.
We can help to find the right doctors for CyberKnife for lung cancer if you have any difficulties with a choice. Bookimed services are free for patients ♥
Known Expertise
Medical Oncologist
Academic Position
Senior Lecturer
Education
Bar-Ilan University, Israel / Computational Biology
Israeli Society for Health-Tech / Fellowship by IMA/ Innovation and Entrepreneurship in Medicine and Health-Tech
Sheba Medical Center and Bar-Ilan University, Israel/ Genomics and Biomedical Informatics
Semmelweis University/Doctor of Medicine
Training and Specialization
Clinical observership in acute oncology, early phase clinical trials and lung cancer/ Guy's and St. Thomas hospital, London, England
Leader Shift, Executive Development Program, Tel-Aviv Sourasky Medical Center
Fellowship Program in Innovation and Entrepreneurship in Medicine and Health-Tech
Resident, Medical Oncology, TASMC, Israel
6th year medical school rotations, Kaplan Medical Center, Israel
Rotation, intensive care unit and pulmonology, Stony Brook hospital, NY, US
Clinical Experience
Leader of the TASMC oncology project of PSIFAS, the Israeli National Genomic Medicine Initiative
PI for study initiator trial: T-Cell Repertoire sequencing as clinical efficacy tool for pembrolizumab (with platinum based chemotherapy) in advanced NSCLC.
PI for study initiator trial: T-cell repertoire sequencing as a clinically efficacy tool for neoadjuvant immunotherapy plus platinum-doublet chemotherapy for resectable NSCLC.
Representative of the National Medical Association for the National Council for the Prevention, Diagnosis and Treatment of Malignant Diseases, as well as head of the oncology field, Leumit HMO
Consultant on drugs and operations in the field of oncology, Leumit HMO
Member of the Helsinki Committee for Clinical Studies, TASMC
Primary investigator (PI) in pharmaceutical phases I&III clinical trials Head of oncology day-care service, TASMC, Israel
Molecular Tumor Board (MTB) moderator of the Israeli Lung Cancer Society
NGS interpretation clinic alongside head of pathology, TASMC, Israel
PI for study initiator trial: Genomic Variant of BCL-2 as a Novel Predictor of Response to Paclitaxel, TASMC, Israel
Medical oncology clinic in the field of lung and breast cancer, TASMC, Israel
Leading sub-investigator (SI) in many phase I-III clinical trials in oncology, including intra-tumoral injections (mRNA, viruses and NO), TASMC, Israel
Courses
Good Clinical Practice ICH GCP R2 & Israeli MOH Guidelines Updated Course
Point-of-Care Ultrasound course, Israeli Medical Association
GCP training Bioforum
GCP training Bioforum
Investigator Site Personnel ICH GCP Training Certificate - TransCelerate BioPharma
Academic Experience
Lecturer in the Department of Medical Education at the Faculty of Medical and Health Sciences at Tel Aviv University
JIMS Journal Club - Instructor for students.
Guidance of Dr. Aviv Berkovich M.D in basic science: cfDNA NGS for identification ofprimary and acquired resistance in patients with Lung Cancer and EGFR mutations.
TASMC, Israel in collaboration with The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, NY USA
Training team for oncology residents, TASMC, Israel
Mentor for new intern, TASMC, Israel
Tutor for medical students in oncology clerkships, Tel-Aviv University, Israel
Honors
Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel
Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel
Sign of honor for reserve medical personnel for the battle in Lebanon, IDF
Completion of residency final examination (shlav Beit) with honors
Israeli society for clinical oncology and radiation therapy (ISCORT) 17 research grant competition winner
Affiliations
Israeli Medical Association (IMA)
Israeli Society for Clinical Oncology and Radiation Therapy (ISCORT)
The Israeli Lung Cancer Group (ILCG)
European Society of Medical Oncology (ESMO)
International Association for the Study of Lung Cancer (IASLC)
The International Society of Liquid Biopsy (ISLB)
The Israeli Society for Health-Tech
Boards
Co-founder, board member and treasurer of the Israeli Acute Oncology Society
Clinical Research Association Board of Directors on behalf of the Israeli Lung Cancer Group
Member of the Trustees of Oncology Innovation, TASMC, Israel
Doctor of Medical Service IDF
Areas of interest
Thoracic malignancies,
early to late phase clinical trials,
intra-tumoral injections,
comprehensive genomic profiling of tumors,
liquid biopsies: cfDNA, TCR rep-seq and epi-Genetics;
cell therapy
Read moreHead of the Onco-Gynecology Department and Lung Cancer Treatment Subdivision, Chief Physician, specializes in Radiotherapy and Brachytherapy in Gynecology.
Read moreChief Physician of Helios Redeyt Oncology Department
Read moreDr. Raj is a highly experienced Surgical Oncologist with 19 years of experience and over 50,000 cancer surgeries performed. He is involved in numerous clinical trials and has many international and national publications to his credit. He specializes in Breast and Thoracic Surgical Oncology and serves as a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at the Maharashtra University of Health Sciences. His belief is in "adding life to years" and improving the quality of life, not just adding years to life.
Read moreFilippo de Marinis is the Director of the Thoracic Oncology Unit at the European Centre for Oncology (Milan, Italy). The doctor leads clinical trials of new methods in the treatment of malignant tumors of the chest organs.
The doctor's experience is more than 30 years.
In 1978, De Marinis completed his studies in Pulmonology at the Sapienza University of Rome. From 1983 to 1986, he specialized in oncology at the Catholic University of the Sacred Heart in Rome. Filippo De Marinis then worked as a physician at the Carlo Forlanini Hospital and the Institute for Clinical Trials and Pneumophysiological Research. Since 2007, he has taught pulmonology at the Campus Biomedico private university in Rome and at the Sapienza University of Rome. Since 2013, the professor has been head of the Thoracic Cancer Unit at the European Oncology Center.
An appointment with Filippo de Marinis lasts from 40 to 60 minutes. During this time, the doctor collects the patient's medical history and compares it with the examination results. In order to establish an accurate diagnosis or plan an operation, the doctor will prescribe additional tests if necessary.
Professor de Marinis is the author of 250 scientific publications in 130 medical journals. As one of the leading experts in the treatment of lung cancer, he has spoken at 300 scientific congresses over the past 5 years.
The doctor participates in national and international clinical trials of new drugs.
Dr. X has a Bachelor of Medicine from Mysore University, India and a Doctor of Medicine in radiotherapy from Banaras Hindu University, India. He is a Diplomate of the National Board of Examination and is a member of the Association of Radiation Oncology of India, Society for Neuro-Oncology, Bangalore Oncology Group, and Indian Association of Hyperthermia Oncology.
Read moreDr. Ahmer Arif Shaikh is an MDS with 3 years of experience in Surgical Oncology. He is an expert in oral cancer, organ preservation and functional rehabilitation of oral cancer patients. He is also proficient in performing major maxillofacial and head & neck surgeries, and has a Fellowship training in Head & Neck Surgical Oncology from HCG Manavata Cancer Centre, Nashik. He is also a researcher with many publications under his name.
Read moreDr. Lalit is a highly experienced oncological surgeon with 10 years of experience and over 10,000 major surgeries performed. He has done his MBBS from MIMER, Pune and MS from GMC Panaji. He has fellowship in Surgical Oncology and worked as a Co-principal Investigator in multiple original research. He is known for his patient friendly and ethical approach, and his main interest is in Minimal Invasive Cancer Surgeries.
Read moreChief Physician of Helios Hospital Berlin-Buch, Head of the Oncology and Palliative Medicine Department, Specialist in Radiotherapy.
Read more